^
    Back
    Association details:
    Biomarker:PLEKHA4 underexpression
    Cancer:Glioma
    Drug Class:Immunotherapy
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C3 – Early Trials
    Source:
    Front Immunol
    Title:

    PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma

    Published date:
    09/25/2023
    Excerpt:
    ...these data demonstrated that patients with low PLEKHA4 expression may benefit from immunotherapy more clinically and PLEKHA4 can serve as an immunotherapy predictor for LGG patients.
    DOI:
    https://doi.org/10.3389/fimmu.2023.1128244